CEN Biotech, Inc. (CENBF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 987.11 Thousand | 626.86 Thousand | - | - | - | - |
| Cost of Revenue | 489.11 Thousand | - | 2.54 Million | 2.57 Million | 4.37 Million | 11.61 Million |
| Gross Profit | 498 Thousand | 626.86 Thousand | -2.54 Million | -2.57 Million | -4.37 Million | -11.61 Million |
| Operating Expenses | 1.76 Million | 18.33 Million | 2.2 Million | 2.57 Million | 3.1 Million | 11.61 Million |
| Selling, General and Administrative Expenses | 2.25 Million | 18.33 Million | 2.2 Million | 2.57 Million | 3.1 Million | 11.61 Million |
| Research and Development Expenses | - | - | - | - | 41 Thousand | 32 Thousand |
| Other Expenses | - | -360.31 Thousand | 20.51 Million | 290 Thousand | -390 Thousand | - |
| Cost and Expenses | 2.25 Million | 18.33 Million | 2.2 Million | 2.57 Million | 3.1 Million | 11.61 Million |
| Operating Income | -1.26 Million | -19.03 Million | 18.31 Million | -2.57 Million | -4.37 Million | -11.61 Million |
| Interest Expense | 252.76 Thousand | 846.74 Thousand | 3.67 Million | 3.3 Million | 2.87 Million | 2.37 Million |
| Income Tax Expense | - | -36.35 Thousand | 24.19 Million | 3.59 Million | -288.64 Thousand | 2.37 Million |
| Earnings before Tax | -1.51 Million | -18.94 Million | 14.24 Million | -5.65 Million | -7.53 Million | -14.08 Million |
| Net Income | -1.51 Million | -18.9 Million | -9.94 Million | -9.25 Million | -7.53 Million | -14.08 Million |
| Earnings Per Share Basic | -0.02 | -0.45 | -0.36 | -0.35 | -0.30 | -1.68 |
| Earnings Per Share Diluted | -0.02 | -0.45 | -0.30 | -0.35 | -0.30 | -1.68 |
| Weighted Average Shares Outstanding | 64.74 Million | 42.41 Million | 27.26 Million | 26.36 Million | 25.3 Million | 8.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.74 Million | 42.41 Million | 32.73 Million | 26.36 Million | 25.3 Million | 8.4 Million |
| Gross Margin | 0.50 | 1.00 | - | - | - | - |
| EBIT Margin | -0.78 | -28.08 | - | - | - | - |
| Profit Margin | -1.53 | -30.16 | - | - | - | - |
| EBITDA | -772.95 Thousand | -17.63 Million | 18.36 Million | -1.83 Million | -4.22 Million | -11.61 Million |
| Earnings Before Tax Margin | -1.28 | -30.37 | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 65.23 Thousand | 151.75 Thousand | 94.06 Thousand | 987.11 Thousand | 308.77 Thousand | 135.85 Thousand |
| Cost of Revenue | - | 14.38 Thousand | 14.28 Thousand | 489.11 Thousand | 169.17 Thousand | 200.88 Thousand |
| Gross Profit | 65.23 Thousand | 137.37 Thousand | 79.78 Thousand | 498 Thousand | 139.6 Thousand | -65.02 Thousand |
| Operating Expenses | 813.14 Thousand | 332.63 Thousand | 478.04 Thousand | 2.25 Million | 628.38 Thousand | 622.23 Thousand |
| Selling, General and Administrative Expenses | 813.14 Thousand | 332.63 Thousand | 478.04 Thousand | - | 628.38 Thousand | 622.23 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | 202.7 Thousand |
| Cost and Expenses | 813.14 Thousand | 347.02 Thousand | 478.04 Thousand | 2.25 Million | 628.38 Thousand | 622.23 Thousand |
| Operating Income | -747.91 Thousand | -195.26 Thousand | -383.98 Thousand | -1.26 Million | -319.6 Thousand | -486.38 Thousand |
| Interest Expense | 38.44 Thousand | 37.75 Thousand | 37.51 Thousand | 252.76 Thousand | 43.5 Thousand | 38.79 Thousand |
| Income Tax Expense | 39.58 Thousand | 4.00 | -20.6 Thousand | -2162.00 | -209.00 | -86.15 Thousand |
| Earnings before Tax | 371.45 Thousand | -225.08 Thousand | -400.88 Thousand | -1.51 Million | -487.48 Thousand | -400.22 Thousand |
| Net Income | 371.45 Thousand | -225.08 Thousand | -380.27 Thousand | -1.51 Million | -487.27 Thousand | -314.07 Thousand |
| Earnings Per Share Basic | 0.01 | -0.00 | -0.01 | - | -0.01 | -0.00 |
| Earnings Per Share Diluted | 0.01 | -0.00 | -0.01 | - | -0.01 | -0.00 |
| Weighted Average Shares Outstanding | 65.25 Million | 65.25 Million | 65.25 Million | 64.74 Million | 64.74 Million | 63.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.25 Million | 65.25 Million | 65.25 Million | 64.74 Million | 64.74 Million | 63.99 Million |
| Gross Margin | 1.00 | 0.91 | 0.85 | 0.50 | 0.45 | -0.48 |
| EBIT Margin | -11.47 | -1.19 | -3.93 | - | -0.89 | -1.18 |
| Profit Margin | 5.69 | -1.48 | -4.04 | -1.53 | -1.58 | -2.31 |
| EBITDA | -747.91 Thousand | -180.87 Thousand | -369.69 Thousand | - | -275.01 Thousand | -160.36 Thousand |
| Earnings Before Tax Margin | -11.47 | -1.29 | -4.08 | -1.28 | -1.04 | -3.58 |
5312
SIRI
093370
NXPLW
9533
000001